Early research (Phase 1)Study completedNCT01497184What this trial is testingInfusion of Allogeneic CD19-Specific T Cells From Peripheral BloodWho this might be right forLeukemiaLymphoma M.D. Anderson Cancer Center 95
Not applicableActive Not RecruitingNCT04914338What this trial is testingA Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell TransplantationWho this might be right forHematopoietic and Lymphoid Cell Neoplasm City of Hope Medical Center 40
Very early researchActive Not RecruitingNCT06765876What this trial is testingCART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I TrialWho this might be right forLeukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more Institute of Hematology and Blood Transfusion, Czech Republic 18
Large-scale testing (Phase 3)Looking for participantsNCT06381817What this trial is testingHaplo-cord HCT vs. Haplo-HCT for T-ALL PatientsWho this might be right forAcute T Cell Lymphoblastic LeukemiaHaploidentical Hematopoietic Stem Cell TransplantationCord Blood The First Affiliated Hospital of Soochow University 146
Not applicableLooking for participantsNCT06941324What this trial is testingSolution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer SurvivorsWho this might be right forHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm University of Michigan Rogel Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Not applicableLooking for participantsNCT07290543What this trial is testingWeb-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer SurvivorsWho this might be right forHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm Northwestern University 578
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385What this trial is testingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more Center for International Blood and Marrow Transplant Research 313
Testing effectiveness (Phase 2)Study completedNCT00019097What this trial is testingVaccine Therapy in Treating Patients With Multiple MyelomaWho this might be right forStage II Multiple MyelomaStage III Multiple MyelomaRefractory Plasma Cell Neoplasm National Cancer Institute (NCI)
Not applicableLooking for participantsNCT02474160What this trial is testingCollection and Storage of Tissue and Blood Samples From Patients With CancerWho this might be right forHematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute LAO 5,000
Testing effectiveness (Phase 2)WithdrawnNCT01269203What this trial is testingEfficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma PatientsWho this might be right forMultiple Myeloma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06111625What this trial is testingShort-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALLWho this might be right forLeukemia, Lymphoid Sichuan University 20
Very early researchStudy completedNCT01174940What this trial is testingTest Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host DiseaseWho this might be right forStem Cell Leukemia of Unclear LineageGraft Versus Host Disease University of Kansas Medical Center 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05434689What this trial is testingCOMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomideWho this might be right forMultiple Myeloma University of Alabama at Birmingham 80
Testing effectiveness (Phase 2)Study completedNCT00702403What this trial is testingNilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CMLWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00997386What this trial is testingReduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure StatesWho this might be right forHematologic NeoplasmsMultiple MyelomaAnemia, Aplastic+2 more University of Arizona 16
Testing effectiveness (Phase 2)Study completedNCT01753453What this trial is testingAn Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem CellsWho this might be right forMultiple Myeloma Sanofi 23
Not applicableLooking for participantsNCT07089927What this trial is testingVirtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS TrialWho this might be right forMalignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm Mayo Clinic 30
Testing effectiveness (Phase 2)Study completedNCT00136903What this trial is testingSafety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)Who this might be right forGraft Vs Host Disease Mesoblast, Inc. 32
Early research (Phase 1)Study completedNCT03340766What this trial is testingStudy Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)Who this might be right forRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) Amgen 31